FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation. The podcast also will have bonus episodes to cover breaking news. Podcast guests analyze FDA regulations, guidances, and policy developments and engage in insightful and revealing conversations with host Wayne Pines, former FDA associate commissioner and author/editor of 16 books about FDA. Subscribers to the podcast include regulatory affairs specialists, food and drug attorneys, policymakers, government officials, strategic planners, and IT and cybersecurity professionals.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
33%
Guest openness
Selective
Sign up to generate a grounded pitch for FDA Watch.
Signup to Generate a PitchFDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation.
Recent episodes include "What's Ahead for FDA and MedTech" (26 October 2026, 50 minutes), "FDA Legal, Regulatory & Compliance Issues, Part 4: Mergers & Acquisitions" (22 October 2026, 43 minutes), and "The Rise of Real-World Evidence in Regulatory Strategy, Part 3: RWE in Accelerated Approvals" (19 October 2026, 43 minutes).
FDA Watch publishes roughly weekly, with episodes averaging 44 minutes across 72 episodes.
Booking probability for FDA Watch is 33%, and the host is rated Selective on guests. FDA Watch requires a Pod Score of 80 or higher. FDA Watch's contact route on record: verified email.
The strongest fits for FDA Watch are Pharmaceuticals, Medical Devices & Supplies and Snacks, Coffee & Other Foods. FDA Watch has a government audience.
FDA Watch is a government podcast with 72 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #59
Wayne chats with Philip Desjardins, Partner at Arnold & Porter; Sean Boyd, Corporate Vice President at QualityHub ; and Rusty Segan, CEO of Medical Scientific Advisors . You'll hear their t akeaways from AdvaMed's...
In this fourth and final part of our series in collaboration with Arnall Golden Gregory LLP, Wayne chats with Alan Minsk, Partner, Chair of the Food & Drug practice, and Co-chair of the Life Sciences industry team at...
Episode #57
In this third part of our series in collaboration with A nalysis Group , Wayne chat s with Dr. Mar al DerSarkissian, Managing Principal at Analysis Group; Dr. Mark Robbins, President and CEO of Kodiak Strategic...
In this second part of our new series in collaboration with A nalysis Group , Wayne chat s with Dr. Mary Beth Ritchey, Principal of Med Tech Epi LLC, and Associate Research Professor at Rutgers University ; and Cori...
Episode #55
Wayne chats with Brian Malkin, Partner at Spencer Fane. You'll hear Brian's thoughts on potential FDA leadership under Heidi Overton, early priorities for drug and biologics companies, implications for drug pricing, AI...
Episode #54
In this first part of our new series in collaboration with A nalysis Group , Wayne chat s with Dr. James Signorovi t ch, Managing Principal at Analysis Group; Bethany Hills, Regulatory Partner at White & Case; and Dr...
Wayne chat s with M eredith Petillo, Vice President of Technical and Regulatory Affairs at the Independent Beauty Association, and Claire Bing, CEO and Founder of Confiance Cosmetic Group . You'll hear their thoughts on...
Episode #52
Wayne chat s with Mason Weeda, Managing Principal at OFW Law and Chair of the firm's FDA Food Practice , and Jessica O'Connell, Partner at Covington and Co-Chair of the firm's Food, Drug, and Device Practice Group...
In this third part of our series in collaboration with Arnall Golden Grego ry LLP , Wayne chat s with Alan Minsk, Partner, Chair of the Food & Drug practice, and Co-chair of the Life Sciences industry team at AGG; and...
Wayne chat s with Cathy Burgess, Partner and Head of the FDA Compliance and Enforcement Team and FDA Practice at Alston & Bird, and Michael Gaba, Food and Drug Vice Chair at Polsinelli . You'll hear their thoughts on...
Wayne chat s with Daniel Kracov, Partner and Chair of the Life Sciences Industry Group at Arnold & Porter, and Dr. Gayatri Rao, Director at Hyman, Phelps & McNamara . You'll hear their thoughts on Operation TrialBlazer...
Episode #47
In this second part of our series in collaboration with Arnall Golden Grego ry LLP , Wayne chat s with Luis Arandia Jr., Partner and Co-chair of International Trade at AGG, and Allison Raley, Partner in AGG's Corporate...
In this first part of our series in collaboration with Arnall Golden Grego ry LLP , Wayne chat s with Gabriel Scannapieco, Partner at A GG and C o-chair of the firm's Life Sciences industry team . Together, they discuss...
Wayne chat s with Paul Kim, Principal of Kendall Square Policy Strategies LLC , and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public Health and former Director of FDA's Center for Food Safety and Applied...
Episode #46
In this third and final part of our series in collaboration with White & Case and BRG , Wayne chat s with Lauren Papenhausen, P artner at White & Case's Boston office , and Edward Buthusiem , Managing Director at BRG...
In this second part of our series in collaboration with White & Case and BRG , Wayne chat s with Bethany Hills, P artner at White & Case , and Dan Troy, Managing Director at BRG . Together, they discuss where pricing...
In this first part of our series in collaboration with White & Case and BRG , Wayne chat s with Bethany Hills, P artner at White & Case's New York office ; Rahul Rao , Partner in White & Case's Washington, D.C., office...
Episode #43
In the final part of our series in collaboration with Skadden , Wayne chat s with Rachel Turow, Head of Skadden's Regulatory Practice; Amy Van Gelder, Head of Skadden's Chicago Litigation Practice; Brett Fleisher, M&A...
Episode #12
Wayne chat s with Dr. Cartier Esham, CEO of Esham Strategies and Executive Director of the Alliance for a Stronger FDA . Together, they discuss FDA's proposed fiscal year 2027 budget, examine how it compares with past...
Wayne chat s with Jessica O'Connell , P artner at Covington and Co-Chair of the firm's Food, Drug, and Device Practice Group; and Rebecca Dandeker, Partner in the Food and Drug P ractice at Wiley Rein . You'll hear...
Recent guests on FDA Watch. Study who booked and why before you pitch.
Medical Director of the University of Texas Southwestern Wound Program, Johns Hopkins Treatment Resistant Esketamine Antidepressant Targeted Depression Clinic
Senior Lecturer in Politics at SOAS University of London, University of St. Andrews
Hall of Fame NFL athletic trainer and sports medicine expert, The Dan Le Batard Show with Stugotz
author & artist & realtor, Hyman, Phelps & McNamara
PitchCentric classifies FDA Watch under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
